Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K. Krämer BK, et al. Among authors: carmellini m. Transplantation. 2012 Sep 15;94(5):492-8. doi: 10.1097/TP.0b013e31825c1d6c. Transplantation. 2012. PMID: 22858806 Free article. Clinical Trial.
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.
Vítko S, Klinger M, Salmela K, Wlodarczyk Z, Tydèn G, Senatorski G, Ostrowski M, Fauchald P, Kokot F, Stefoni S, Perner F, Claesson K, Castagneto M, Heemann U, Carmellini M, Squifflet JP, Weber M, Segoloni G, Bäckman L, Sperschneider H, Krämer BK. Vítko S, et al. Among authors: carmellini m. Transplantation. 2005 Dec 27;80(12):1734-41. doi: 10.1097/01.tp.0000188300.26762.74. Transplantation. 2005. PMID: 16378069 Clinical Trial.
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
Krämer BK, Klinger M, Wlodarczyk Z, Ostrowski M, Midvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Vítko S, Senatorski G, Salmela K, Nordström J. Krämer BK, et al. Among authors: carmellini m. Clin Transplant. 2010 Jan-Feb;24(1):E1-9. doi: 10.1111/j.1399-0012.2009.01162.x. Epub 2009 Nov 18. Clin Transplant. 2010. PMID: 19925464 Clinical Trial.
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C. Montagnino G, et al. Among authors: carmellini m. Transplant Proc. 2005 Mar;37(2):788-90. doi: 10.1016/j.transproceed.2004.11.033. Transplant Proc. 2005. PMID: 15848532 Clinical Trial.
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus.
Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F; ADHERE study investigators. Rummo OO, et al. Among authors: carmellini m. Transpl Int. 2017 Jan;30(1):83-95. doi: 10.1111/tri.12878. Epub 2016 Nov 28. Transpl Int. 2017. PMID: 27754567 Free article. Clinical Trial.
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
Budde K, Rostaing L, Maggiore U, Piotti G, Surace D, Geraci S, Procaccianti C, Nicolini G, Witzke O, Kamar N, Albano L, Büchler M, Pascual J, Gutiérrez-Dalmau A, Kuypers D, Wekerle T, Głyda M, Carmellini M, Tisone G, Midtvedt K, Wennberg L, Grinyó JM. Budde K, et al. Among authors: carmellini m. Transpl Int. 2022 Mar 21;35:10225. doi: 10.3389/ti.2021.10225. eCollection 2022. Transpl Int. 2022. PMID: 36017158 Free PMC article. Clinical Trial.
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.
Segoloni G, Bonomini V, Maresca MC, Arisi L, Gonzalez-Molina M, Tarantino A, del Castillo D, Ortuño J, Carmellini M, Capdevila L, Arias M, Garcia J, Rigotti P. Segoloni G, et al. Among authors: carmellini m. Transpl Int. 2000;13 Suppl 1:S336-40. doi: 10.1007/s001470050356. Transpl Int. 2000. PMID: 11112027 Clinical Trial.
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.
Montagnino G, Sandrini S, Iorio B, Schena FP, Carmellini M, Rigotti P, Cossu M, Altieri P, Salvadori M, Stefoni S, Corbetta G, Ponticelli C. Montagnino G, et al. Among authors: carmellini m. Nephrol Dial Transplant. 2008 Feb;23(2):707-14. doi: 10.1093/ndt/gfm621. Epub 2007 Sep 21. Nephrol Dial Transplant. 2008. PMID: 17890244 Clinical Trial.
A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: results at 7 years.
Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Mastrangelo F, Castagneto M, Salvadori M, Valente U, Cossu M, Federico S, Pisani F, Montagnino G, Messina M, Arisi L, Carmellini M, Piredda GB, Ponticelli C. Tarantino A, et al. Among authors: carmellini m. Transplant Proc. 1998 Aug;30(5):1729-31. doi: 10.1016/s0041-1345(98)00407-2. Transplant Proc. 1998. PMID: 9723258 Clinical Trial. No abstract available.
123 results